1. Home
  2. NNNN vs NPWR Comparison

NNNN vs NPWR Comparison

Compare NNNN & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • NPWR
  • Stock Information
  • Founded
  • NNNN 2021
  • NPWR 2010
  • Country
  • NNNN Germany
  • NPWR United States
  • Employees
  • NNNN N/A
  • NPWR N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NPWR Industrial Machinery/Components
  • Sector
  • NNNN Health Care
  • NPWR Energy
  • Exchange
  • NNNN Nasdaq
  • NPWR Nasdaq
  • Market Cap
  • NNNN 267.7M
  • NPWR 148.7M
  • IPO Year
  • NNNN 2025
  • NPWR N/A
  • Fundamental
  • Price
  • NNNN $6.63
  • NPWR $1.98
  • Analyst Decision
  • NNNN
  • NPWR Buy
  • Analyst Count
  • NNNN 0
  • NPWR 2
  • Target Price
  • NNNN N/A
  • NPWR $4.00
  • AVG Volume (30 Days)
  • NNNN 32.8K
  • NPWR 617.2K
  • Earning Date
  • NNNN 01-01-0001
  • NPWR 05-12-2025
  • Dividend Yield
  • NNNN N/A
  • NPWR N/A
  • EPS Growth
  • NNNN N/A
  • NPWR N/A
  • EPS
  • NNNN 0.06
  • NPWR N/A
  • Revenue
  • NNNN $8,185,146.00
  • NPWR $250,000.00
  • Revenue This Year
  • NNNN N/A
  • NPWR $308.00
  • Revenue Next Year
  • NNNN N/A
  • NPWR $1,811.08
  • P/E Ratio
  • NNNN $116.38
  • NPWR N/A
  • Revenue Growth
  • NNNN 21.95
  • NPWR 42.86
  • 52 Week Low
  • NNNN $5.18
  • NPWR $1.62
  • 52 Week High
  • NNNN $7.82
  • NPWR $14.28
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • NPWR 39.36
  • Support Level
  • NNNN N/A
  • NPWR $1.79
  • Resistance Level
  • NNNN N/A
  • NPWR $1.93
  • Average True Range (ATR)
  • NNNN 0.00
  • NPWR 0.15
  • MACD
  • NNNN 0.00
  • NPWR 0.12
  • Stochastic Oscillator
  • NNNN 0.00
  • NPWR 81.82

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

Share on Social Networks: